InvestorsHub Logo
Followers 22
Posts 1379
Boards Moderated 0
Alias Born 03/31/2017

Re: Justfactsmam post# 346151

Monday, 02/15/2021 7:20:49 AM

Monday, February 15, 2021 7:20:49 AM

Post# of 403568
I agree Justfactsmam, I'll place my bets on reputable Dr. Aarthi Narayanan and not someone has it out for the company.

Time is quickly running out and we will see how Brilacidin will do in human trials.

Go Leo & IPIX!

Lets be clear...the truth of this statement...HAS NOT BEEN ESTABLISHED OR PROVEN ANYTHING.

Until and unless OG speaks with ALL involved in the series of RBL Tests, which were ultimately the subject of the Peer Reveiw Artilce...he is makeing huge presumptions...and therefore blowing hot air.
...

As "YOU" WELL KNOW ..Warren Kyle Weston... does not have a medical/scientific background to influence Dr.Narayanan or any serious scientist in an RBL. Non-substantive scientific participation...still get one listed as a "contributor"...

To believe your and OG's "assumptions" and "unsubstantiated conclusions" ... would require one to assume Dr. Aarthi Narayanan, an expert on Remdesivir, was relegated to a cleaning lady in the lab.

Just the opposite likely occurred...Jane and W. Klye Weston contributed by providing prior research or data, etc...menial tasks FROM AFAR...not directing or even influencing the tests and methodology...

IMO Dr. Aarthi Narayanan has a great interest in protecting her reputation from delusional allegations.

Quote:
OG highlighted the influence IPIX (Warren and Jane) had over the GMU in terms of test criteria, structure, etc... I'm maybe less concerned about the protocol manipulation and more just wondering if I'm reading the data correctly.


Innovation Pharmaceuticals’ Brilacidin for the Treatment of COVID-19 Receives FDA Fast Track Designation

FDA Grants IND Approval for Phase 2 Clinical Trial of Innovation Pharmaceuticals - Brilacidin for Treating
COVID-19

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News